Thorne Healthtech Inc
NASDAQ:THRN
Intrinsic Value
Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. [ Read More ]
The intrinsic value of one THRN stock under the Base Case scenario is 16.56 USD. Compared to the current market price of 10.19 USD, Thorne Healthtech Inc is Undervalued by 38%.
Valuation Backtest
Thorne Healthtech Inc
Run backtest to discover the historical profit from buying and selling THRN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Thorne Healthtech Inc's business.
What risks and challenges
does Thorne Healthtech Inc face in the near future?
Summarize the latest earnings report
of Thorne Healthtech Inc.
Provide P/E
for Thorne Healthtech Inc and its competitors.
Balance Sheet Decomposition
Thorne Healthtech Inc
Current Assets | 135.5m |
Cash & Short-Term Investments | 17.1m |
Receivables | 25.6m |
Other Current Assets | 92.8m |
Non-Current Assets | 147.1m |
Long-Term Investments | 2.4m |
PP&E | 101.6m |
Intangibles | 34.9m |
Other Non-Current Assets | 8.1m |
Current Liabilities | 56.2m |
Accounts Payable | 40.6m |
Accrued Liabilities | 10m |
Short-Term Debt | 560k |
Other Current Liabilities | 5.2m |
Non-Current Liabilities | 72.4m |
Long-Term Debt | 25.2m |
Other Non-Current Liabilities | 47.2m |
Earnings Waterfall
Thorne Healthtech Inc
Revenue
|
255.9m
USD
|
Cost of Revenue
|
-127.6m
USD
|
Gross Profit
|
128.4m
USD
|
Operating Expenses
|
-114.9m
USD
|
Operating Income
|
13.5m
USD
|
Other Expenses
|
6.9m
USD
|
Net Income
|
20.3m
USD
|
Free Cash Flow Analysis
Thorne Healthtech Inc
What is Free Cash Flow?
THRN Profitability Score
Profitability Due Diligence
Thorne Healthtech Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Thorne Healthtech Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
THRN Solvency Score
Solvency Due Diligence
Thorne Healthtech Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Score
Thorne Healthtech Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
THRN Price Targets Summary
Thorne Healthtech Inc
According to Wall Street analysts, the average 1-year price target for THRN is 7 USD .
Ownership
THRN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
THRN Price
Thorne Healthtech Inc
Average Annual Return | -15.36% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -65% |
Market Capitalization | 549.4m USD |
Shares Outstanding | 54 036 800 |
Percentage of Shares Shorted | 1.99% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. The company is headquartered in Summerville, South Carolina and currently employs 496 full-time employees. The company went IPO on 2021-09-23. The firm is developing solutions and personalized approaches to health and well-being. The firm's brands, Thorne and Onegevity, provides insights and personalized data, products and services that help individuals take a proactive approach to maintain their health over their lifetime. The firm's Onegevity, is a multi-omics database that uses artificial intelligence (AI) and machine learning to provide insights, with its nutritional supplements. Its Thorne products support the optimization of health and include health tests, education and nutritional supplement products. The firm offers health tests to generate comprehensive, personalized, molecular portraits for its customers. Its portfolio of health tests includes tests focused on sleep, stress, weight management, gut health, heavy metals, and biological age.
Contact
IPO
Employees
Officers
The intrinsic value of one THRN stock under the Base Case scenario is 16.56 USD.
Compared to the current market price of 10.19 USD, Thorne Healthtech Inc is Undervalued by 38%.